We’ve all heard of Ozempic by now. It’s only licensed for use as a diabetes treatment in the UK and US, but it's widely used ‘off label’ to help people lose weight. So much so, in fact, that its name ...

SHARON Vickers was one of the first people to try the brand new ‘Ozempic pill’ after her weight loss efforts stalled. Now, she says she has no plans of stopping – as it’s ...

A NEW jab set to rival the likes of Mounjaro and Wegovy helped people lose up to 22 per cent of their body weight in less ...

As many as 1.6 million adults in the UK used weight loss drugs like Mounjaro or Wegovy in the last year, and 3.3 million more have expressed an interest in taking GLP-1s this year. So, with demand at ...

Better regulation and enforcement urged before launch of oral treatments, which criminals are likely to try to exploit ...

Brands are claiming their products will help to burn fat, block carbs or suppress your appetite. Or, that their products can increase GLP-1 production (the appetite-regulating hormone that ...

Our collective appetite for weight loss drugs has become pretty much insatiable over the past few years. It’s thought that around 1.5 million people in the UK are on GLP-1 agonist medications to curb ...

A researcher has highlighted a variety claims made by weight loss supplement sellers and how 'egregious' some of them can be ...

Online retailers are making outlandish claims about the weight loss benefits of some supplements, an investigation has found. Research by Which? looked at supplements sold on popular online ...

Danish drugmaker Novo Nordisk has launched a pill version of its weight loss treatment Wegovy in the United States, following approval from the US Food and Drug Administration (FDA). The tablet ...

The disruptive force of weight loss drugs: How GLP-1s do more than shed pounds - The impacts of weight-loss medications reach ...

‘Misleading’ claims used to advertise weight-loss supplements, watchdog finds - Which? said it found evidence of Amazon, eBay ...